Bruce G. Allen Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$191K Buy
2,442
+22
+0.9% +$1.77K 0.12% 82
2026
Q1
$210K Buy
2,420
+444
+22% +$42.5K 0.14% 76
2025
Q4
$190K Buy
1,976
+85
+4% +$8.26K 0.13% 80
2025
Q3
$180K Buy
1,891
+227
+14% +$20.9K 0.13% 81
2025
Q2
$145K Sell
1,664
-194
-10% -$16.5K 0.11% 106
2025
Q1
$167K Sell
1,858
-97
-5% -$8.68K 0.13% 89
2024
Q4
$156K Buy
1,955
+58
+3% +$5.02K 0.13% 97
2024
Q3
$171K Buy
1,897
+49
+3% +$4.12K 0.13% 98
2024
Q2
$145K Sell
1,848
-3
-0.2% -$246 0.12% 103
2024
Q1
$161K Buy
1,851
+8
+0.4% +$683 0.13% 92
2023
Q4
$152K Buy
+1,843
New +$140K 0.14% 96

Other funds holding MDT

Bruce G. Allen Investments's MDT Position: Q2 2026 in Review

Bruce G. Allen Investments increased its Medtronic (MDT) stake by 0.91% in Q2 2026, buying an estimated $1.77K and bringing the position to 2,442 shares worth $191K. The position accounts for 0.12% of the portfolio, ranked #82.

Bruce G. Allen Investments first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $210K in Q1 2026. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bruce G. Allen Investments held 2,442 shares of Medtronic worth $191K as of Q2 2026.
  • Bruce G. Allen Investments bought 22 Medtronic shares in Q2 2026, an estimated $1.77K.
  • Medtronic made up 0.12% of Bruce G. Allen Investments's portfolio in Q2 2026, its #82 holding.
  • Bruce G. Allen Investments first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Bruce G. Allen Investments's Medtronic position peaked at $210K in Q1 2026.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bruce G. Allen Investments's 13F filing for Q2 2026, filed 31 Jul 2026.